The balance sheet is volatile, with equity swinging from -$58.1M in Q1 2026 to $215.6M in Q2 2026 due to milestone recognition, while a $112.3M debt load and a cumulative retained earnings deficit of -$701.8M highlight the company's reliance on external capital.
MeiraGTx Holdings plc (MGTX) balance sheet — 10-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 |
|---|
| Total Current Assets | 218.35M | 91.76M | 123.52M | 159.62M | 154.34M | 183.24M | 272.58M | 268.98M | 74.65M | 11.48M | 19.09M |
| Cash & Short-Term Investments | 143.17M | 65.93M | 103.66M | 129.57M | 115.52M | 137.7M | 209.52M | 227.23M | 68.08M | 8.55M | 17.48M |
| Cash Only | 143.17M | 65.93M | 103.66M | 129.57M | 115.52M | 137.7M | 209.52M | 227.23M | 68.08M | 8.55M | 17.48M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 44.26M | 18.29M | 10.63M | 23.41M | 29.02M | 35.02M | 55.41M | 37.11M | 0 | 0 | 0 |
| Days Sales Outstanding | 21.19 | 82 | 116.57 | 609.72 | 665.41 | 339.02 | 1.3K | 1.02K | - | - | - |
| Inventory | 0 | 0 | 385K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | 5.91 | - | - | - | - | - | - | - | - |
| Other Current Assets | 26.93M | 1.53M | 2.02M | 1.02M | 1.67M | 2.42M | 564.44K | 170.59K | 4.63M | 965.23K | 400.96K |
| Total Non-Current Assets | 178.1M | 152.67M | 146.23M | 167.12M | 163.9M | 136.92M | 91.12M | 54.91M | 22.24M | 14.38M | 3.46M |
| Property, Plant & Equipment | 134.28M | 141.93M | 135.65M | 156.24M | 154.09M | 126.29M | 87.12M | 52.86M | 22.01M | 14.26M | 3.02M |
| Fixed Asset Turnover | 2.85x | 0.57x | 0.25x | 0.09x | 0.10x | 0.30x | 0.18x | 0.25x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 421K | 578K | 821K | 1.12M | 2.08M | 2.57M | 2.97M | 777.65K | 0 | 0 | 0 |
| Long-Term Investments | 62.35M | 6.75M | 6.75M | 6.77M | 6.33M | 6.66M | 0 | 123.38K | 123.38K | 123.38K | 444.84K |
| Other Non-Current Assets | 3.56M | 3.41M | 3.01M | 3M | 1.4M | 1.4M | 1.03M | 1.15M | 105.08K | 0 | 0 |
| Total Assets | 396.45M | 244.43M | 269.75M | 326.74M | 318.24M | 320.16M | 363.7M | 323.89M | 96.89M | 25.85M | 22.55M |
| Asset Turnover | 1.48x | 0.33x | 0.12x | 0.04x | 0.05x | 0.12x | 0.04x | 0.04x | - | - | - |
| Asset Growth % | 62.6% | -9.39% | -17.44% | 2.67% | -0.6% | -11.97% | 12.29% | 234.27% | 274.77% | 14.65% | - |
| Total Current Liabilities | 58.1M | 122.56M | 60.78M | 67.08M | 82.07M | 68.13M | 54.15M | 49.2M | 15.5M | 21.4M | 6.04M |
| Accounts Payable | 11.67M | 10.07M | 23.59M | 16.04M | 16.62M | 15.35M | 7.13M | 3.76M | 3.04M | 7.06M | 1.47M |
| Days Payables Outstanding | 490.05 | 758.64 | 361.85 | - | - | - | - | - | 541 | 3.79K | 2.21K |
| Short-Term Debt | 0 | 24.65M | 0 | 0 | 0 | 0 | 2.58M | 1.67M | 27.2K | 1.44M | 0 |
| Deferred Revenue (Current) | 11.95M | 1.78M | 4.83M | 2.93M | 15.12M | 21.82M | 23.54M | 25.68M | 11.99M | 10.19M | -6.01K |
| Other Current Liabilities | 15.11M | 63.09M | 12.1M | 41.28M | 16.23M | 6.03M | 17.09M | 11.23M | 6.14M | 2.68M | 1.96M |
| Current Ratio | 3.76x | 0.75x | 2.03x | 2.38x | 1.88x | 2.69x | 5.03x | 5.47x | 4.82x | 0.54x | 3.16x |
| Quick Ratio | 3.76x | 0.75x | 2.03x | 2.38x | 1.88x | 2.69x | 5.03x | 5.47x | 4.82x | 0.54x | 3.16x |
| Cash Conversion Cycle | -468.86 | - | -239.38 | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 122.57M | 127.67M | 141.14M | 121.49M | 118.43M | 66.64M | 70.99M | 83.89M | 336.48K | 51.82M | 33.65M |
| Long-Term Debt | 100M | 49.69M | 73.22M | 72.12M | 71.03M | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 43.72M | 11.46M | 7.52M | 12.95M | 17.33M | 20.36M | 19.67M | 21.5M | 7.1K | 34.3K | 5.46K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 186K | 196K | 213.72K | 195.05K | -201.26K | -266.29K | -588.49K |
| Other Non-Current Liabilities | 1.45M | 1.4M | 2.82M | 2.4M | 2.44M | 3.03M | 1.81M | 1.65M | 329.38K | 51.78M | 33.64M |
| Total Liabilities | 180.67M | 250.22M | 201.92M | 188.57M | 200.5M | 134.76M | 125.14M | 133.09M | 15.84M | 73.22M | 39.69M |
| Total Debt | 112.32M | 88.69M | 84.8M | 89.26M | 92.25M | 23.73M | 22.25M | 23.18M | 34.3K | 1.51M | 11.47K |
| Net Debt | -30.84M | 22.75M | -18.86M | -40.3M | -23.27M | -113.97M | -187.27M | -204.05M | -68.05M | -7.04M | -17.47M |
| Debt / Equity | 0.52x | - | 1.25x | 0.65x | 0.78x | 0.13x | 0.09x | 0.12x | 0.00x | - | - |
| Debt / EBITDA | 0.41x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.11x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | 20.06x | -8.36x | -10.14x | -5.34x | -25.21x | -275.25x | -415.60x | -1125.19x | -2336.42x | -739.21x | -788.70x |
| Total Equity | 215.78M | -5.79M | 67.83M | 138.18M | 117.74M | 185.4M | 238.56M | 190.8M | 81.06M | -47.37M | -17.14M |
| Equity Growth % | 6663.37% | -108.54% | -50.91% | 17.36% | -36.5% | -22.28% | 25.03% | 135.39% | 271.14% | -176.36% | - |
| Book Value per Share | 2.30 | -0.07 | 0.97 | 2.45 | 2.61 | 4.20 | 6.32 | 5.75 | 4.28 | -5.53 | -0.89 |
| Total Shareholders' Equity | 215.57M | -5.79M | 67.83M | 138.18M | 117.74M | 185.4M | 238.56M | 190.8M | 81.06M | -47.37M | -17.14M |
| Common Stock | 3K | 3K | 3K | 2K | 2K | 2K | 1.72K | 1.43K | 1.06K | 342 | 342 |
| Retained Earnings | -701.82M | -816.22M | -702.02M | -554.23M | -470.2M | -340.59M | -261.03M | -203.04M | -148.29M | -65.42M | -34.38M |
| Treasury Stock | -18.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 3.25M | 2.41M | -3.72M | -1.44M | 6.05M | -2.67M | -4.9M | -1.79M | 293.67K | -2.02M | -661.11K |
| Minority Interest | 209K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying MGTX stock.
As of 2025, MeiraGTx Holdings plc (MGTX) had total assets of $244.4M including $91.8M in current assets.
MeiraGTx Holdings plc (MGTX) carries total debt of $88.7M, offset by $65.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
MeiraGTx Holdings plc (MGTX) has total shareholders' equity (book value) of $-5.8M ($-0.07 book value per share). Book value represents the net worth of the company belonging to common stock holders.
MeiraGTx Holdings plc (MGTX) reported a current ratio of 0.75x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Imminent capital raise required
Metrics are mathematically derived from official filings.
Balance Sheet Volatility Driven by Milestone Timing
The balance sheet has swung from a negative equity position of -$58.1M in Q1 2026 to a positive $215.6M in Q2 2026, a dramatic reversal driven by the recognition of a large non-cash revenue milestone from a partner, not by operational cash generation.
This extreme volatility in equity and total assets, which nearly doubled in a single quarter, underscores the company's reliance on lumpy, non-recurring collaboration payments to maintain its financial structure. The trajectory is not one of steady strengthening but of periodic, event-driven inflections that mask the underlying operational burn. Investors should monitor whether the next major milestone can be achieved before the current cash cushion is depleted.
Cash Position Rebuilt but Burn Rate Persists
Cash and equivalents surged to $143.2M in Q2 2026 from $71.5M in Q1, providing a temporary buffer, but the company's high fixed-cost structure and negative operating margins suggest this runway remains limited without further capital infusions.
The current ratio improved dramatically to 3.76, indicating strong short-term liquidity, but this is a direct result of the milestone cash inflow. The underlying operational burn, which averaged over $40M per quarter prior to Q2 2026, implies the current cash position may only fund operations for a few more quarters. The company's history of operating with a tight cash cushion warrants close monitoring for signs of another capital raise or asset sale.
Modest Leverage Amidst Equity Volatility
Total debt of $112.3M in Q2 2026 represents a manageable D/E ratio of 0.52, but this metric is highly volatile due to swings in equity, and the debt load appears strategic to fund the capital-intensive manufacturing infrastructure.
The debt level has remained relatively stable between $80M and $112M over the past ten quarters, suggesting it is a deliberate part of the capital structure rather than a sign of distress. However, the D/E ratio has been meaningless in quarters with negative equity, highlighting that leverage analysis must be paired with cash flow durability. The debt appears to be financing long-term assets like the manufacturing facilities, but its refinancing risk increases if clinical timelines extend.
Heavy Investment in Manufacturing Infrastructure
Property, plant, and equipment net of $134.3M constitutes over a third of total assets, reflecting the company's high-risk, vertically integrated strategy to own and operate its own cGMP manufacturing facilities.
This asset-heavy model creates a significant barrier to entry but also ties up substantial capital in facilities that are not yet generating commercial revenue. The quality of these assets is contingent on the clinical and commercial success of the pipeline; if programs fail, the PPE could become impaired. The minimal goodwill on the balance sheet suggests the asset base is primarily organic, reducing one type of intangible risk.
Massive Accumulated Deficit Undermines Equity Base
Retained earnings stand at a cumulative deficit of -$701.8M, indicating the company has consumed far more capital than it has generated since inception, a hallmark of a pre-revenue biotech funding its operations through equity and debt.
The equity base is fragile and highly sensitive to non-cash accounting events, as evidenced by the swing from negative to positive equity in a single quarter. The lack of positive retained earnings means the company has no internal buffer and is entirely dependent on external capital markets or strategic partnerships to fund its operations. This structure amplifies the risk for equity holders, as any future dilutive raise will occur from a position of historical capital consumption.
Deferred Revenue Decline Signals Partner Commitment Shift
Deferred revenue plummeted from $66.8M in Q1 2026 to $16.5M in Q2 2026, a $50.3M reduction that likely represents the recognition of previously deferred collaboration payments, but could also indicate a restructuring or termination of future obligations with a key partner.
This sharp decline is the most non-obvious risk on the balance sheet. While it likely reflects the recognition of revenue from the Janssen collaboration, it also means a significant portion of the company's future contracted revenue has now been earned and removed from the liability side. If this reflects a restructuring of the partnership, as hinted in recent context flags, it could signal a reduced commitment from a major partner and a future revenue cliff. This warrants investigation into the specific terms of the collaboration changes.